Inventor · disambiguated record
Jeffrey P. Mcmahon
Also filed as: MCMAHON JEFFREY · MCMAHON JEFFREY P
33 granted patents·4 pending applications·191 citations·filing 2009–2021
97Inventor score
Top patents by PatentIndex Score
37 records- 0198US9834545B2Modulators of chemokine receptorsCHEMOCENTRYX INC·Filed 2016·Granted Dec 5, 2017·26 cites·33 claims
- 0297US9809581B2Inhibitors of CXCR2CHEMOCENTRYX INC·Filed 2016·Granted Nov 7, 2017·23 cites·29 claims
- 0396US11691985B2Macrocyclic immunomodulatorsCHEMOCENTRYX INC·Filed 2021·Granted Jul 4, 2023·4 cites·20 claims
- 0496US11059834B2Macrocyclic immunomodulatorsCHEMOCENTRYX INC·Filed 2019·Granted Jul 13, 2021·10 cites·18 claims
- 0596US10919852B2Immunomodulator compoundsCHEMOCENTRYX INC·Filed 2018·Granted Feb 16, 2021·15 cites·25 claims
- 0695US11708326B2Immunomodulator compoundsCHEMOCENTRYX INC·Filed 2020·Granted Jul 25, 2023·4 cites·25 claims
- 0795US9783540B2Substituted tetrahydropyrans as CCR2 modulatorsCHEMOCENTRYX INC·Filed 2016·Granted Oct 10, 2017·7 cites·45 claims
- 0894US11142521B2Substituted anilines as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2019·Granted Oct 12, 2021·4 cites·6 claims
- 0994US10464934B2Substituted tetrahydropyrans as CCR2 modulatorsCHEMOCENTRYX INC·Filed 2017·Granted Nov 5, 2019·5 cites·13 claims
- 1094US10370363B2Inhibitors of CXCR2CHEMOCENTRYX INC·Filed 2017·Granted Aug 6, 2019·6 cites·13 claims
- 1194US10336736B2Modulators of chemokine receptorsCHEMOCENTRYX INC·Filed 2017·Granted Jul 2, 2019·6 cites·24 claims
- 1293US10392405B2Macrocyclic immunomodulatorsCHEMOCENTRYX INC·Filed 2018·Granted Aug 27, 2019·13 cites·46 claims
- 1392US9169261B2CXCR7 antagonistsCHEMOCENTRYX INC·Filed 2013·Granted Oct 27, 2015·13 cites·26 claims
- 1491US11059825B2CXCR7 antagonistsCHEMOCENTRYX INC·Filed 2019·Granted Jul 13, 2021·2 cites·11 claims
- 1591US10988464B2Modulators of chemokine receptorsCHEMOCENTRYX INC·Filed 2019·Granted Apr 27, 2021·3 cites·16 claims
- 1691US8916601B2Aza-aryl 1H-pyrazol-1-YL benzene sulfonamidesCHEMOCENTRYX INC·Filed 2013·Granted Dec 23, 2014·12 cites·20 claims
- 1790US11040960B2Inhibitors of CXCR2CHEMOCENTRYX INC·Filed 2019·Granted Jun 22, 2021·3 cites·14 claims
- 1890US9758512B2Substituted anilines as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2016·Granted Sep 12, 2017·6 cites·24 claims
- 1987US9567323B2Substituted anilines as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2014·Granted Feb 14, 2017·6 cites·9 claims
- 2086US10407417B2Substituted anilines as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2017·Granted Sep 10, 2019·3 cites·12 claims
- 2186US9783544B2CXCR7 antagonistsCHEMOCENTRYX INC·Filed 2015·Granted Oct 10, 2017·4 cites·26 claims
- 2285US10596163B2Aza-aryl 1H-pyrazol-1-yl benzene sulfonamidesCHEMOCENTRYX INC·Filed 2018·Granted Mar 24, 2020·3 cites·19 claims
- 2381US8288373B2Modulators of CXCR7CHEN XI·Filed 2009·Granted Oct 16, 2012·5 cites·42 claims
- 2480US10137120B2Aza-aryl 1H-pyrazol-1-yl benzene sulfonamidesCHEMOCENTRYX INC·Filed 2014·Granted Nov 27, 2018·2 cites·19 claims
- 2578US11884654B2Substituted anilines as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2021·Granted Jan 30, 2024·0 cites·15 claims
- 2678US11834452B2CXCR7 antagonistsCHEMOCENTRYX INC·Filed 2021·Granted Dec 5, 2023·0 cites·14 claims
- 2778US10287292B2CXCR7 antagonistsCHEMOCENTRYX INC·Filed 2017·Granted May 14, 2019·1 cites·7 claims
- 2877US8853202B2Modulators of CXCR7CHEN XI·Filed 2010·Granted Oct 7, 2014·4 cites·10 claims
- 2976US2022047575A1Aza-aryl 1h-pyrazol-1-yl benzene sulfonamidesCHEMOCENTRYX INC·Filed 2021·Application pending·0 cites
- 3075US11207294B2Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2CHEMOCENTRYX INC·Filed 2019·Granted Dec 28, 2021·1 cites·6 claims
- 3174US12054484B2Substituted tetrahydropyrans as CCR2 modulatorsCHEMOCENTRYX INC·Filed 2021·Granted Aug 6, 2024·0 cites·8 claims
- 3274US11945805B2Inhibitors of CXCR2CHEMOCENTRYX INC·Filed 2021·Granted Apr 2, 2024·0 cites·9 claims
- 3373US11820759B2Modulators of chemokine receptorsCHEMOCENTRYX INC·Filed 2021·Granted Nov 21, 2023·0 cites·8 claims
- 3471US11684606B2Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2CHEMOCENTRYX INC·Filed 2021·Granted Jun 27, 2023·0 cites·15 claims
- 3570US2020121688A1Substituted tetrahydropyrans as ccr2 modulatorsCHEMOCENTRYX INC·Filed 2019·Application pending·0 cites
- 3668US2020197386A1Aza-Aryl 1H-Pyrazol-yl Benzene SulfonamidesCHEMOCENTRYX INC·Filed 2020·Application pending·0 cites
- 3735US2011014121A1Modulators of cxcr7CHEMOCENTRYX INC·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →